{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:24:21Z","timestamp":1791998661261,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["118S721"],"award-info":[{"award-number":["118S721"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.cimid.2022.101927","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:16:35Z","timestamp":1670249795000},"page":"101927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immunogenic evaluation of multi-epitope peptide-loaded PCPP microparticles as a vaccine candidate against Toxoplasma Gondii"],"prefix":"10.1016","volume":"92","author":[{"given":"Rabia","family":"Yilmaz-Ozturk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Calik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslin","family":"Ustun-Karatop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Cakir-Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cimid.2022.101927_bib1","first-page":"1","article-title":"Toxoplasma gondii vaccine candidates: a concise review","author":"Mamaghani","year":"2022","journal-title":"Ir. J. Med. Sci."},{"issue":"16","key":"10.1016\/j.cimid.2022.101927_bib2","first-page":"11","article-title":"Toxoplasma gondii in foods","author":"Mar\u00edn-Garc\u00eda","year":"2022","journal-title":"Preval., Control, Saf. Foods"},{"key":"10.1016\/j.cimid.2022.101927_bib3","doi-asserted-by":"crossref","unstructured":"\u00c7ak\u0131r Ko\u00e7 R., \u00d6zdemir B. A Global Problem of Toxoplasmosis. 2018. p. 305\u2013317.","DOI":"10.1016\/B978-0-12-813806-9.00015-9"},{"key":"10.1016\/j.cimid.2022.101927_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des., Dev. Ther."},{"issue":"6","key":"10.1016\/j.cimid.2022.101927_bib5","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1645\/20-157","article-title":"Review of DNA vaccine approaches against the parasite toxoplasma gondii","volume":"107","author":"Warner","year":"2021","journal-title":"J. Parasitol."},{"key":"10.1016\/j.cimid.2022.101927_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00053","article-title":"A one health approach to vaccines against Toxoplasma gondii","volume":"15","author":"Innes","year":"2019","journal-title":"Food Waterborne Parasitol."},{"key":"10.1016\/j.cimid.2022.101927_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111711","article-title":"Recent progress on anti-Toxoplasma drugs discovery: design, synthesis and screening","volume":"183","author":"Deng","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.cimid.2022.101927_bib8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"issue":"6","key":"10.1016\/j.cimid.2022.101927_bib9","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cimid.2022.101927_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108029","article-title":"The influence of component structural arrangement on peptide vaccine immunogenicity","volume":"60","author":"Alharbi","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.cimid.2022.101927_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-0716-1892-9_8","article-title":"Developments in vaccine adjuvants","volume":"2412","author":"Firdaus","year":"2022","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"issue":"15","key":"10.1016\/j.cimid.2022.101927_bib12","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1039\/D2BM00061J","article-title":"Recent progress in synthetic self-adjuvanting vaccine development","volume":"10","author":"Ariawan","year":"2022","journal-title":"Biomater. Sci."},{"issue":"3","key":"10.1016\/j.cimid.2022.101927_bib13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00441-018-2929-4","article-title":"Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action","volume":"374","author":"Magiri","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cimid.2022.101927_bib14","article-title":"Polyphosphazenes as adjuvants for animal vaccines and other medical applications","volume":"9","author":"Chand","year":"2021"},{"issue":"11","key":"10.1016\/j.cimid.2022.101927_bib15","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.vaccine.2009.12.069","article-title":"Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens","volume":"28","author":"Shim","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.cimid.2022.101927_bib16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1021\/acs.molpharmaceut.7b00118","article-title":"PCPP-adjuvanted respiratory syncytial virus (RSV) sF subunit vaccine: self-assembled supramolecular complexes enable enhanced immunogenicity and protection","volume":"14","author":"Cayatte","year":"2017","journal-title":"Mol. Pharm."},{"issue":"52","key":"10.1016\/j.cimid.2022.101927_bib17","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1016\/j.vaccine.2010.09.080","article-title":"PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice","volume":"28","author":"Garlapati","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2022.101927_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.meegid.2017.07.014","article-title":"First detection and genetic characterization of Toxoplasma gondii in market-sold oysters in China","volume":"54","author":"Cong","year":"2017","journal-title":"Infect., Genet. Evol."},{"issue":"1\u20133","key":"10.1016\/j.cimid.2022.101927_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0142-9612(97)00227-5","article-title":"Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions","volume":"19","author":"Andrianov","year":"1998","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.cimid.2022.101927_bib20","first-page":"353","article-title":"Fabrication, characterization, in vitro drug release and glucose uptake activity of 14-deoxy, 11, 12-didehydroandrographolide loaded polycaprolactone nanoparticles","volume":"12","author":"Kamaraj","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.cimid.2022.101927_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127046","article-title":"Structural analysis, molecular dynamics and docking calculations of skin protective tripeptide and design, characterization, cytotoxicity studies of its PLGA nanoparticles","volume":"1200","author":"Kokcu","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cimid.2022.101927_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1051\/parasite\/2017004","article-title":"Protective immunity against toxoplasmosis in mice induced by single-dose immunization with rSAG1\/2 protein released from poly(lactide-co-glycolide) microparticles","volume":"24","author":"Chuang","year":"2017","journal-title":"Parasite (Paris, Fr. )"},{"key":"10.1016\/j.cimid.2022.101927_bib23","first-page":"140","article-title":"Study on growth of Toxoplasma gondii tissue cyst in laboratory mouse. Jundishapur","volume":"2","author":"Hooshyar","year":"2009","journal-title":"J. Microbiol."},{"key":"10.1016\/j.cimid.2022.101927_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104764","article-title":"Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB\/c mice","volume":"153","author":"Dodangeh","year":"2021","journal-title":"Microb. Pathog."},{"issue":"116","key":"10.1016\/j.cimid.2022.101927_bib25","doi-asserted-by":"crossref","DOI":"10.3791\/54596","article-title":"Isolation and activation of murine lymphocytes","author":"Lim","year":"2016","journal-title":"J. Vis. Exp.: JoVE"},{"key":"10.1016\/j.cimid.2022.101927_bib26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ijbiomac.2021.10.023","article-title":"Preparation of chitosan nanoparticles as Ginkgo biloba extract carrier: In vitro neuroprotective effect on oxidative stress-induced human neuroblastoma cells (SH-SY5Y)","volume":"192","author":"Karavelioglu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.cimid.2022.101927_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.actatropica.2017.09.007","article-title":"Vaccination with a DNA vaccine encoding Toxoplasma gondii ROP54 induces protective immunity against toxoplasmosis in mice","volume":"176","author":"Yang","year":"2017","journal-title":"Acta Trop."},{"key":"10.1016\/j.cimid.2022.101927_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1051\/parasite\/2020021","article-title":"Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against toxoplasma gondii infection in mice","volume":"27","author":"Zhu","year":"2020","journal-title":"Parasite (Paris, Fr.)"},{"issue":"15","key":"10.1016\/j.cimid.2022.101927_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.85955","article-title":"Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii","volume":"1","author":"El Bissati","year":"2016","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.cimid.2022.101927_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5455\/javar.2019.f329","article-title":"Epitope-based vaccine as a universal vaccination strategy against Toxoplasma gondii infection: A mini-review","volume":"6","author":"Hajissa","year":"2019","journal-title":"J. Adv. Vet. Anim. Res."},{"key":"10.1016\/j.cimid.2022.101927_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2019.05.003","article-title":"C57BL\/6 mice immunized with synthetic peptides from Toxoplasma gondii surface and microneme immunodominant antigens are able to decrease parasite burden in the brain tissues","volume":"196","author":"Barros","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.cimid.2022.101927_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/pharmaceutics14020359","article-title":"Poly(lactic acid)-based microparticles for drug delivery applications: an overview of recent advances","volume":"14","author":"Vlachopoulos","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.cimid.2022.101927_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060606","article-title":"Nano-microparticle platforms in developing next-generation vaccines","volume":"9","author":"Cappellano","year":"2021","journal-title":"Vaccines"},{"issue":"9","key":"10.1016\/j.cimid.2022.101927_bib34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccin."},{"issue":"3","key":"10.1016\/j.cimid.2022.101927_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00441-018-2929-4","article-title":"Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action","volume":"374","author":"Magiri","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.cimid.2022.101927_bib36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","article-title":"B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii","volume":"68","author":"Sayles","year":"2000","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.cimid.2022.101927_bib37","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1007\/s00436-013-3425-0","article-title":"Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice","volume":"112","author":"Qu","year":"2013","journal-title":"Parasitol. Res."},{"issue":"11","key":"10.1016\/j.cimid.2022.101927_bib38","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3252","article-title":"Detection of antigen-specific T cells in spleens of vaccinated mice applying 3[H]-thymidine incorporation assay and luminex multiple cytokine analysis technology","volume":"9","author":"Agallou","year":"2019","journal-title":"Bio-Protoc."},{"key":"10.1016\/j.cimid.2022.101927_bib39","article-title":"Immunization with a DNA vaccine encoding the toxoplasma gondii\u2019 s GRA39 prolongs survival and reduce brain cyst formation in a murine model","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.cimid.2022.101927_bib40","article-title":"The impact of the antigenic composition of chimeric proteins on their immunoprotective activity against chronic toxoplasmosis in mice","volume":"7","author":"Gatkowska","year":"2019","journal-title":"Vaccin. [Internet]"},{"issue":"9","key":"10.1016\/j.cimid.2022.101927_bib41","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1586\/14760584.2015.1061938","article-title":"Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice","volume":"14","author":"Zhang","year":"2015","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.cimid.2022.101927_bib42","article-title":"Toxoplasma gondii infection damages the perineuronal nets in a murine model","volume":"115","author":"Meurer","year":"2020","journal-title":"Mem. do Inst. Oswaldo Cruz"},{"issue":"16","key":"10.1016\/j.cimid.2022.101927_bib43","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.vaccine.2009.01.100","article-title":"Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant","volume":"27","author":"Hedhli","year":"2009","journal-title":"Vaccine"}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957122001849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957122001849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:48:38Z","timestamp":1758955718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957122001849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":43,"alternative-id":["S0147957122001849"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2022.101927","relation":{},"ISSN":["0147-9571"],"issn-type":[{"value":"0147-9571","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenic evaluation of multi-epitope peptide-loaded PCPP microparticles as a vaccine candidate against Toxoplasma Gondii","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2022.101927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101927"}}